Edwards Lifesciences Corporation
Bioprosthetic tissue having a reduced propensity for in vivo calcification

Last updated:

Abstract:

A bioprosthetic tissue having a reduced propensity to calcify in vivo, the bioprosthetic tissue. The bioprosthetic tissue comprises an aldehyde cross-linked and stressed bioprosthetic tissue comprising exposed calcium, phosphate or immunogenic binding sites that have been reacted with a calcification mitigant. The bioprosthetic tissue has a reduced propensity to calcify in vivo as compared to aldehyde cross-linked bioprosthetic tissue that has not been stressed and reacted with the calcification mitigant.

Status:
Grant
Type:

Utility

Filling date:

7 Oct 2019

Issue date:

19 Apr 2022